1. What Anticoagulant Registries Are Revealing

3. Clinical Trials vs Registries

4. AFNET Registry: Cardiologist-run Centers Adhere Better to Antithrombotic Guidelines

5. VKA vs Dabigatran in "Real Life" (US Medicare)

6. Clinical Trials vs Registries

7. GLORIA-AF

8. GARFIELD

9. Antithrombotic Therapy in AF 2004-06 EUROHEART[a] and AFNET[b] Registry Analyses

10. Antithrombotic Therapy by Stroke Risk Score

11. Anticoagulant Use By CHA2DS2-VASc Score

12. GLORIA-AF Increasing Uptake of NOACs vs VKAs in Most Regions

13. GLORIA-AF: Increasing NOAC Uptake in Europe- Phase I versus Phase II

14. Real-World Studies EORP – AF pilot

15. NOAC Meta-analysis Stroke or SEE

16. Why Don't Elderly Patients Receive NOACs/VKAs?

17. Anticoagulant + Antiplatelet Therapy in Patients With AF at Risk for Stroke

18. PREFER-AF Combination Therapy (OAC and Antiplatelets) in Europe in 2012

19. Dabigatran and Cardioversion

20. New NOAC Cardioversion Trials

21. Summary

22. Abbreviations

23. References

24. References (cont)

25. References (cont)

26. References (cont)

27. References (cont)